Releases
THMO
--
0.00%
--
  • All
  • Financials
  • Insiders
More
Webull provides the latest ThermoGenesis Holdings Inc (THMO) stock and general news. This information may help you make smarter investment decisions.
About THMO
ThermoGenesis Holdings, Inc., formerly Cesca Therapeutics Inc., develops, commercializes and markets a range of automated technologies for chimeric antigen receptor (CAR)-T and other cell-based therapies. It offers a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Its CAR-TXpress platform is its cellular processing platform. It offers cell manufacturing tools and services in the global cell and gene therapy market.
More